Kyras Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Kyras Therapeutics General Information

Description

Developer of drugs designed to cure cancer and other developmental disorders. The company's drugs address currently incurable cancers and developmental disorders caused by RAS gene mutations, enabling healthcare providers to cure their patients.

Contact Information

Website
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 430 East 29th Street
  • Suite 1005
  • New York, NY 10016
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kyras Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Apr-2018 000 Completed Out of Business
3. Grant 16-Nov-2017 000 000 Completed Generating Revenue
2. Early Stage VC (Series A) 10-Dec-2015 $5M $5M 0000 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Kyras Therapeutics’s complete valuation and funding history, request access »

Kyras Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00 00 00 00 00.000
To view Kyras Therapeutics’s complete cap table history, request access »

Kyras Therapeutics Executive Team (3)

Name Title Board Seat Contact Info
Joseph Vacca Ph.D Chief Scientific Officer
Brent Stockwell Ph.D Co-Founder, Board Member & Advisor
Carlo Rizzuto Ph.D Co-Founder, Board Member & Chief Executive Officer
To view Kyras Therapeutics’s complete executive team members history, request access »

Kyras Therapeutics Board Members (3)

Name Representing Role Since
Bradley Bolzon Ph.D Versant Venture Management Board Member 000 0000
Brent Stockwell Ph.D Kyras Therapeutics Co-Founder, Board Member & Advisor 000 0000
Carlo Rizzuto Ph.D Self Co-Founder, Board Member & Chief Executive Officer 000 0000
To view Kyras Therapeutics’s complete board members history, request access »